APLS - APELLIS PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Apellis Pharmaceuticals Inc. - APLS | Benzinga
NEW ORLEANS, Aug. 29, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 2, 2023 to file lead plaintiff applications in a securities class action lawsuit against Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), if they purchased the Company's shares between January 28, 2021 and July 28, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Delaware.
Get Help
Apellis investors should visit us at https://claimsfiler.com/cases/nasdaq-apls/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Apellis and certain of its ...